4004
Company Profile

Viking Therapeutics

3.0
Avg Sentiment

Sentiment Over Time

Analysis Timeline

2.0
Score
2026-01-24

"Biotech company with GLP-1 candidates in clinical trials, potential future competitor or acquisition target."

Source: GLP-1 Gold Rush: Shifting Dynamics & Supply Chain Opportunities
4.0
Score
2026-01-19

"Das Startup notierte gut 5% höher aufgrund erfolgreicher Abnehm-Spritzen."

Source: Handelskrieg, KI-Energiekrise und Trumps Zölle: Was Anleger wissen müssen
← Back to Companies Index